{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:31:47Z","timestamp":1779935507028,"version":"3.53.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T00:00:00Z","timestamp":1427241600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s15010-015-0763-0","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T06:27:56Z","timestamp":1427178476000},"page":"751-754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature"],"prefix":"10.1007","volume":"43","author":[{"given":"Sanjiv M.","family":"Baxi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,25]]},"reference":[{"key":"763_CR1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4103\/0974-777X.68535","volume":"2","author":"PS Loomba","year":"2010","unstructured":"Loomba PS, Taneja J, Mishra B. Methicillin and vancomycin resistant S. aureus in hospitalized patients. J Glob Infect Dis. 2010;2:275\u201383. doi: 10.4103\/0974-777X.68535 .","journal-title":"J Glob Infect Dis"},{"key":"763_CR2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/cid\/cis492","volume":"55","author":"LD Saravolatz","year":"2012","unstructured":"Saravolatz LD, Pawlak J, Johnson LB. In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates. Clin Infect Dis. 2012;55:582\u20136. doi: 10.1093\/cid\/cis492 .","journal-title":"Clin Infect Dis"},{"key":"763_CR3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","volume":"50","author":"L Cui","year":"2006","unstructured":"Cui L, Tominaga E, Neoh HM, Hiramatsu K. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother. 2006;50:1079\u201382. doi: 10.1128\/AAC.50.3.1079-1082.2006 .","journal-title":"Antimicrob Agents Chemother"},{"key":"763_CR4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.01516-13","volume":"58","author":"AA Bhalodi","year":"2014","unstructured":"Bhalodi AA, Hagihara M, Nicolau DP, Kuti JL. In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure. Antimicrob Agents Chemother. 2014;58:672\u20137. doi: 10.1128\/AAC.01516-13 .","journal-title":"Antimicrob Agents Chemother"},{"key":"763_CR5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/cid\/cir340","volume":"53","author":"A Dhand","year":"2011","unstructured":"Dhand A, Bayer AS, Pogliano J, Yang SJ, Bolaris M, Nizet V, et al. Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis. 2011;53:158\u201363. doi: 10.1093\/cid\/cir340 .","journal-title":"Clin Infect Dis"},{"key":"763_CR6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/jac\/dks006","volume":"67","author":"TT Ho","year":"2012","unstructured":"Ho TT, Cadena J, Childs LM, Gonzalez-Velez M, Lewis JS. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy. J Antimicrob Chemother. 2012;67:1267\u201370. doi: 10.1093\/jac\/dks006 .","journal-title":"J Antimicrob Chemother"},{"key":"763_CR7","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/jac\/dkt009","volume":"68","author":"K Jongsma","year":"2013","unstructured":"Jongsma K, Joson J, Heidari A. Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report. J Antimicrob Chemother. 2013;68:1444\u20135. doi: 10.1093\/jac\/dkt009 .","journal-title":"J Antimicrob Chemother"},{"key":"763_CR8","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1099\/jmm.0.2008\/000588-0","volume":"57","author":"MH Murthy","year":"2008","unstructured":"Murthy MH, Olson ME, Wickert RW, Fey PD, Jalali Z. Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate. J Med Microbiol. 2008;57:1036\u20138. doi: 10.1099\/jmm.0.2008\/000588-0 .","journal-title":"J Med Microbiol"},{"key":"763_CR9","author":"G Sakoulas","year":"2014","unstructured":"Sakoulas G, Moise PA, Casapao AM, Nonejuie P, Olson J, Okumura CY, et al. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline. Clin Ther. 2014. doi: 10.1016\/j.clinthera.2014.05.061 .","journal-title":"Clin Ther"},{"key":"763_CR10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijantimicag.2013.07.005","volume":"42","author":"HM Polenakovik","year":"2013","unstructured":"Polenakovik HM, Pleiman CM. Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature. Int J Antimicrob Agents. 2013;42:450\u20135. doi: 10.1016\/j.ijantimicag.2013.07.005 .","journal-title":"Int J Antimicrob Agents"},{"key":"763_CR11","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/jac\/dku085","volume":"69","author":"P Tattevin","year":"2014","unstructured":"Tattevin P, Boutoille D, Vitrat V, Van Grunderbeeck N, Revest M, Dupont M, et al. Salvage treatment of methicillin-resistant staphylococcal endocarditis with ceftaroline: a multicentre observational study. J Antimicrob Chemother. 2014;69:2010\u20133. doi: 10.1093\/jac\/dku085 .","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"763_CR12","doi-asserted-by":"crossref","first-page":"ofu046","DOI":"10.1093\/ofid\/ofu046","volume":"1","author":"V Fabre","year":"2014","unstructured":"Fabre V, Ferrada M, Buckel WR, Avdic E, Cosgrove SE. Ceftaroline in combination with trimethoprim-sulfamethoxazole for salvage therapy of methicillin-resistant Staphylococcus aureus bacteremia and endocarditis. Open Forum Infect Dis. 2014;1(2):ofu046. doi: 10.1093\/ofid\/ofu046 .","journal-title":"Open Forum Infect Dis"},{"key":"763_CR13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s10156-012-0449-9","volume":"19","author":"JC Lin","year":"2013","unstructured":"Lin JC, Aung G, Thomas A, Jahng M, Johns S, Fierer J. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients. J Infect Chemother. 2013;19:42\u20139. doi: 10.1007\/s10156-012-0449-9 .","journal-title":"J Infect Chemother"},{"key":"763_CR14","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1128\/AAC.00857-10","volume":"54","author":"LA Marcos","year":"2010","unstructured":"Marcos LA, Camins BC. Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin. Antimicrob Agents Chemother. 2010;54:5376\u20138. doi: 10.1128\/AAC.00857-10 .","journal-title":"Antimicrob Agents Chemother"},{"key":"763_CR15","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1155\/2012\/138470","volume":"23","author":"R Yu","year":"2012","unstructured":"Yu R, Dale SE, Yamamura D, Stankus V, Lee C. Daptomycin-nonsusceptible, vancomycin-intermediate, methicillin-resistant Staphylococcus aureus endocarditis. Can J Infect Dis Med Microbiol. 2012;23:e48\u201350.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"763_CR16","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/AAC.00559-07","volume":"51","author":"K Julian","year":"2007","unstructured":"Julian K, Kosowska-Shick K, Whitener C, Roos M, Labischinski H, Rubio A, et al. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis. Antimicrob Agents Chemother. 2007;51:3445\u20138. doi: 10.1128\/AAC.00559-07 .","journal-title":"Antimicrob Agents Chemother"},{"key":"763_CR17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10096-010-1128-3","volume":"30","author":"SJ Hal van","year":"2011","unstructured":"van Hal SJ, Paterson DL, Gosbell IB. Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naive patient\u2014a review of the literature. Eur J Clin Microbiol Infect Dis. 2011;30:603\u201310. doi: 10.1007\/s10096-010-1128-3 .","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"763_CR18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1345\/aph.1M665","volume":"44","author":"NM Ahmad","year":"2010","unstructured":"Ahmad NM, Rojtman AD. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin. Ann Pharmacother. 2010;44:918\u201321. doi: 10.1345\/aph.1M665 .","journal-title":"Ann Pharmacother"},{"key":"763_CR19","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/AAC.00093-09","volume":"53","author":"HS Sader","year":"2009","unstructured":"Sader HS, Rhomberg PR, Jones RN. Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009;53:3162\u20135. doi: 10.1128\/AAC.00093-09 .","journal-title":"Antimicrob Agents Chemother"},{"key":"763_CR20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1309\/AJCPMV1P0VKUAZRD","volume":"133","author":"R Nadarajah","year":"2010","unstructured":"Nadarajah R, Post LR, Liu C, Miller SA, Sahm DF, Brooks GF. Detection of vancomycin-intermediate Staphylococcus aureus with the updated Trek-Sensititre System and the MicroScan System. Comparison with results from the conventional Etest and CLSI standardized MIC methods. Am J Clin Pathol. 2010;133:844\u20138. doi: 10.1309\/AJCPMV1P0VKUAZRD .","journal-title":"Am J Clin Pathol."},{"key":"763_CR21","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1128\/AAC.02308-12","volume":"57","author":"BJ Werth","year":"2013","unstructured":"Werth BJ, Steed ME, Kaatz GW, Rybak MJ. Evaluation of ceftaroline activity against heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-intermediate methicillin-resistant S. aureus strains in an in vitro pharmacokinetic\/pharmacodynamic model: exploring the \u201cseesaw effect\u201d. Antimicrob Agents Chemother. 2013;57:2664\u20138. doi: 10.1128\/AAC.02308-12 .","journal-title":"Antimicrob Agents Chemother"},{"key":"763_CR22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40121-014-0023-0","volume":"3","author":"KE Barber","year":"2014","unstructured":"Barber KE, Ireland CE, Bukavyn N, Rybak MJ. Observation of \u201cseesaw effect\u201d with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains. Infect Dis Ther. 2014;3:35\u201343. doi: 10.1007\/s40121-014-0023-0 .","journal-title":"Infect Dis Ther"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-015-0763-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-015-0763-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-015-0763-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T09:25:42Z","timestamp":1566465942000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-015-0763-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,25]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1007\/s15010-015-0763-0","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,25]]}}}